Latest Insider Transactions at Gene Biotherapeutics, Inc. (CRXM)
This section provides a real-time view of insider transactions for Gene Biotherapeutics, Inc. (CRXM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Gene Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Gene Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2021
|
Christopher J Jemapete > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+4.76%
|
$0
$0.4 P/Share
|
|
Mar 16
2021
|
Christopher J Jemapete > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+7.32%
|
$0
$0.04 P/Share
|